# DST Health

> DST Health is the legacy healthcare business associated with DST Systems, acquired by SS&C Technologies in 2018. Its medical administration and analytics capabilities sit within today’s SS&C Health portfolio, alongside pharmacy technology and services for health plans, PBMs and providers.

- **Headquarters:** Windsor, United States
- **Products:** AMISYS Advance, CareAnalyzer, RxNova, DomaniRx, Healthcare operations outsourcing
- **Notable:** Twelve healthcare organizations selected CareAnalyzer in a company announcement dated April 2013., DST Systems acquisition by SS&C completed April 16, 2018 at approximately $5.4 billion enterprise value for the entire parent., Related DomaniRx platform launched January 1, 2024.

## Products & services

- **AMISYS Advance** — Medical claims administration with turnkey, hosted and business process outsourcing deployment options.
- **CareAnalyzer** — Population health and provider analytics integrating the Johns Hopkins ACG System with quality measurement including HEDIS.
- **RxNova** — Legacy pharmacy claims-processing technology contributed under a non-exclusive license to the DomaniRx venture.
- **DomaniRx** — Related SS&C Health joint-venture pharmacy benefit administration platform; launched January 1, 2024.
- **Healthcare operations outsourcing** — Enrollment, claims, payment, workflow and call center services within the current SS&C Health portfolio.
- **Member and provider engagement** — Digital benefit self-service and prior authorization technology and services within SS&C Health.

## Achievements

- Twelve healthcare organizations selected CareAnalyzer in a company announcement dated April 2013.
- DST Systems acquisition by SS&C completed April 16, 2018 at approximately $5.4 billion enterprise value for the entire parent.
- Related DomaniRx platform launched January 1, 2024.
- SS&C Health reported processing more than 600 million claims in 2025.

## Latest updates

- **2026-02** — SS&C’s 2025 Form 10-K reported more than 600 million claims processed by SS&C Health during 2025.
- **2025-03** — The 2024 Form 10-K disclosed a $75 million DomaniRx capital call in 2024, of which SS&C contributed $60.2 million.

## Links

- Website: https://www.ssctech.com/industry/health
- LinkedIn: https://www.linkedin.com/company/dst-health-solutions

---

Profile page: https://yespress.io/dst-health
Published by YesPress — https://yespress.io
Last updated: 2026-10-17